Provided by Tiger Trade Technology Pte. Ltd.

Illumina

213.63
-1.9600-0.91%
Post-market: 214.000.3700+0.17%16:46 EDT
Volume:2.02M
Turnover:430.02M
Market Cap:32.26B
PE:39.78
High:214.90
Open:213.74
Low:208.98
Close:215.59
52wk High:231.81
52wk Low:88.00
Shares:151.00M
Float Shares:149.05M
Volume Ratio:1.05
T/O Rate:1.35%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.37
EPS(LYR):5.45
ROE:32.34%
ROA:8.67%
PB:11.37
PE(LYR):39.20

Loading ...

Illumina Inc : Canaccord Genuity Cuts Target Price to $140 From $150

THOMSON REUTERS
·
May 01

Analysts Have Conflicting Sentiments on These Healthcare Companies: Cardinal Health (CAH) and Illumina (ILMN)

TIPRANKS
·
May 01

Illumina lifts 2026 outlook and expands share buybacks

TIPRANKS
·
May 01

Illumina Q1 FY26 GAAP EPS rises 6.1% to $0.87; revenue increases 4.8% to $1.09 billion

Reuters
·
May 01

GUIDANCE: (ILMN) Illumina Expects Fiscal 2026 Revenue Range $4.52B-$4.62B, vs. FactSet Est of $4.54B

MT Newswires Live
·
May 01

Illumina Q1 Adj. EPS $1.15 Beats $1.05 Estimate, Sales $1.090B Beat $1.073B Estimate

Benzinga Earnings
·
May 01

BRIEF-Illumina Q1 Adjusted EPS USD 1.15 Vs. IBES Estimate USD 1.05

Reuters
·
May 01

Illumina Outlook FY Total Revenue of $4.52-$4.62 Billion

THOMSON REUTERS
·
May 01

Illumina Inc - Board Authorizes Additional $1.5 Bln in Share Repurchases on April 28, 2026

THOMSON REUTERS
·
May 01

Illumina Q1 Adjusted EBIT Margin 21.9%

THOMSON REUTERS
·
May 01

Illumina Outlook FY Adjusted EPS USD 5.15-5.3

THOMSON REUTERS
·
May 01

Illumina Posts Higher 1Q Profit, Sales, Citing Growing Demand for NovaSeq X

Dow Jones
·
May 01

Stock Track | Illumina Soars 5.18% Intraday on Industry M&A Hopes and Patent Litigation

Stock Track
·
May 01

Illumina (ILMN) Valuation Check After DRAGEN v4.5 Launch And Pediatric Genomics Partnership

Simply Wall St.
·
Apr 27

Sweden's Devyser Q1 net sales rise 12.9%, operating profit turns positive

Reuters
·
Apr 27

Did DRAGEN v4.5’s AI Genomics Push Just Shift Illumina’s (ILMN) Investment Narrative?

Simply Wall St.
·
Apr 26

Earning Preview: Illumina Q1 revenue is expected to increase by 4.12%, and institutional views are bearish

Earnings Agent
·
Apr 23

UPS, Netflix, BlackRock And A Health Care Stock On CNBC's 'Final Trades'

Benzinga
·
Apr 20

Illumina (ILMN) Valuation Check After DRAGEN v4.5 Launch And Major Pediatric Genomics Partnership

Simply Wall St.
·
Apr 18

Dragen V4.5 Supports Illumina's New Trupath Genome and 5-Base Assays, Drives Insights Across Germline, Oncology, and Multiomic Workflows

THOMSON REUTERS
·
Apr 16